Daiken Medical Co., Ltd. provided non-consolidated earnings forecast for the six months ending September 30, 2024 and full year ending March 31, 2025. For the six months, the company expects net sales of ¥4,950 million, operating profit of ¥700 million, profit of ¥480 million and earnings per share of ¥16.71.

For the year, the company expects net sales of ¥10,100 million, operating profit of ¥1,500 million, profit of ¥1,030 million and earnings per share of ¥35.85.